Literature DB >> 10447885

Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins.

M A Scidmore-Carlson1, E I Shaw, C A Dooley, E R Fischer, T Hackstadt.   

Abstract

Chlamydia trachomatis is a bacterial obligate intracellular parasite that replicates within a vacuole, termed an inclusion, that does not fuse with lysosomes. Within 2 h after internalization, the C. trachomatis inclusion ceases to interact with the endocytic pathway and, instead, becomes fusogenic with exocytic vesicles containing exogenously synthesized NBD-sphingomyelin. Both fusion of exocytic vesicles and long-term avoidance of lysosomal fusion require early chlamydial gene expression. Modification of the chlamydial inclusion probably occurs through the expression and insertion of chlamydial protein(s) into the inclusion membrane. To identify candidate inclusion membrane proteins, antisera were raised against a total membrane fraction purified from C. trachomatis-infected HeLa cells. By indirect immunofluorescence, this antisera recognized the inclusion membrane and, by immunoblot analysis, recognized three chlamydial-specific antigens of approximate molecular weights 15, 18 and 21 kDa. IncG, encoding an 18 kDa and 21 kDa doublet chlamydial antigen, was identified by screening a C. trachomatis, serovar L2, genomic expression library. Three additional genes, incD, incE and incF, were co-transcribed with incG. Monospecific antisera against each of the four genes of this operon demonstrated that the gene products were localized to the chlamydial inclusion membrane. Immediately downstream from the operon containing incD-G was the C. trachomatis homologue of incA. Like IncD, E, F and G, C. trachomatis IncA is also localized to the inclusion membrane. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis demonstrated that IncD-G, but not incA, are transcribed within the first 2 h after internalization, making them candidates for chlamydial factors required for the modification of the nascent chlamydial inclusion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447885     DOI: 10.1046/j.1365-2958.1999.01523.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  82 in total

1.  Normal IncA expression and fusogenicity of inclusions in Chlamydia trachomatis isolates with the incA I47T mutation.

Authors:  Y Pannekoek; A van der Ende; P P Eijk; J van Marle; M A de Witte; J M Ossewaarde; A J van den Brule; S A Morré; J Dankert
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 2.  Genome sequencing and our understanding of chlamydiae.

Authors:  D D Rockey; J Lenart; R S Stephens
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  A meta-analysis of affinity purification-mass spectrometry experimental systems used to identify eukaryotic and chlamydial proteins at the Chlamydia trachomatis inclusion membrane.

Authors:  Macy G Olson; Scot P Ouellette; Elizabeth A Rucks
Journal:  J Proteomics       Date:  2019-11-21       Impact factor: 4.044

Review 4.  Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism.

Authors:  Hossam Abdelsamed; Jan Peters; Gerald I Byrne
Journal:  Future Microbiol       Date:  2013-09       Impact factor: 3.165

5.  Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates.

Authors:  Kenneth A Fields; Elizabeth R Fischer; David J Mead; Ted Hackstadt
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

6.  A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.

Authors:  Sandra Muschiol; Leslie Bailey; Asa Gylfe; Charlotta Sundin; Kjell Hultenby; Sven Bergström; Mikael Elofsson; Hans Wolf-Watz; Staffan Normark; Birgitta Henriques-Normark
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

7.  Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.

Authors:  K Wolf; H J Betts; B Chellas-Géry; S Hower; C N Linton; K A Fields
Journal:  Mol Microbiol       Date:  2006-09       Impact factor: 3.501

8.  The GTPase Rab4 interacts with Chlamydia trachomatis inclusion membrane protein CT229.

Authors:  K A Rzomp; A R Moorhead; M A Scidmore
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

9.  Chlamydial type III secretion system is encoded on ten operons preceded by sigma 70-like promoter elements.

Authors:  P Scott Hefty; Richard S Stephens
Journal:  J Bacteriol       Date:  2006-10-20       Impact factor: 3.490

10.  Absence of Specific Chlamydia trachomatis Inclusion Membrane Proteins Triggers Premature Inclusion Membrane Lysis and Host Cell Death.

Authors:  Mary M Weber; Jennifer L Lam; Cheryl A Dooley; Nicholas F Noriea; Bryan T Hansen; Forrest H Hoyt; Aaron B Carmody; Gail L Sturdevant; Ted Hackstadt
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.